ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,748Medicare Part D Prescriptions Filled, Including Refills

Rank: 123 out of 2604

$570K Total Retail Price of All Prescriptions

Rank: 140 out of 2604

225 Patients Receiving at Least One Drug in Part D
47%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 225 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

48% of this provider’s 225 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

3% of this provider’s 4,539 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

43 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
HYDROCODONE-ACETAMINOPHEN 714 236 S3 1 1
SIMVASTATIN 304 149 2 2
LISINOPRIL 289 174 3 3
FUROSEMIDE 256 132 4 8
RANITIDINE HCL 256 104 4 25
METOPROLOL TARTRATE 222 123 6 9
HYDROCHLOROTHIAZIDE 220 97 7 10
OMEPRAZOLE 209 78 8 5
AMLODIPINE BESYLATE 200 101 9 6
AMMONIUM LACTATE 175 47 10 215
TRAMADOL HCL 165 113 11 15
GABAPENTIN 133 77 12 12
ISOSORBIDE MONONITRATE ER 128 54 13 38
LOSARTAN POTASSIUM 124 70 14 20
HYDRALAZINE HCL 123 63 15 85
LANTUS 117 43 16 40
RISPERIDONE 117 95 16 65
CARVEDILOL 114 34 18 26
TAMSULOSIN HCL 109 96 19 30
CITALOPRAM HBR 109 67 19 18
WARFARIN SODIUM 108 95 21 13
CLOPIDOGREL 107 48 22 39
ACETAMINOPHEN-CODEINE 104 61 S3 23 60
METFORMIN HCL 103 60 24 7
NYSTOP 96 23 25 163
PROAIR HFA 95 28 26 27
CYCLOBENZAPRINE HCL 94 28 R 27 43
TRAZODONE HCL 89 71 28 46
POTASSIUM CHLORIDE 88 45 29 16
ATORVASTATIN CALCIUM 85 40 30 19
DONEPEZIL HCL 85 83 30 28
SERTRALINE HCL 84 28 32 23
VENTOLIN HFA 80 27 33 63
LEVOTHYROXINE SODIUM 79 50 34 4
ENALAPRIL MALEATE 79 43 34 50
FENTANYL 73 65 S2 36 48
NAMENDA 72 72 37 37
HEPARIN SODIUM 72 50 37 330
LEVETIRACETAM 68 28 39 96
PANTOPRAZOLE SODIUM 66 54 40 64
ADVAIR DISKUS 62 16 41 41
DESOXIMETASONE 60 13 42 200
CARISOPRODOL 59 13 R 43 54
PLAVIX 59 36 43 75
PROMETHAZINE HCL 56 23 R 45 88
MORPHINE SULFATE ER 54 0 S2 46 58
FAMOTIDINE 52 35 47 68
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 19, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.